A multiple-dose pharmacokinetic dose selection study of hydroxyprogesterone (LPCN 1107) in pregnant women

Trial Profile

A multiple-dose pharmacokinetic dose selection study of hydroxyprogesterone (LPCN 1107) in pregnant women

Recruiting
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs Hydroxyprogesterone (Primary)
  • Indications Preterm birth
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Feb 2016 Top-line results published in a Lipocine media release.
    • 12 Nov 2015 According to a Lipocine media release, first patient from this trial has been dosed.
    • 28 Sep 2015 Status changed from planning to recruiting according to a Lipocine media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top